Notification to the Oslo Stock Exchange re purchase of own shares
June 07, 2004 03:09 ET
|
Telenor
After this transaction Telenor ASA owns a total of 45,370,072 shares, of which 40,913,172 shares were decided cancelled at the Annual General Meeting May 6, 2004. These shares will be cancelled during...
Melding til Oslo Børs vedr. kjøp av egne aksjer
June 07, 2004 03:02 ET
|
Telenor
Etter denne transaksjonen eier Telenor ASA totalt 45.370.072 aksjer, hvorav 40.913.172 ble besluttet slettet av Telenors generalforsamling 6. mai 2004. De vil bli slettet i løpet av juli 2004 når...
UTi Worldwide Posts Record Quarterly Gross and Net Revenues and Net Income
June 07, 2004 03:01 ET
|
UTi Worldwide
RANCHO DOMINGUEZ, Calif., June 7, 2004 (PRIMEZONE) -- UTi Worldwide Inc. (Nasdaq:UTIW) today reported gains in gross and net revenues, operating income and net income for the fiscal 2005 first...
Positive results of first phase II study in new class of oral diabetes drugs
June 07, 2004 03:00 ET
|
Novartis Pharma AG
Positive results of first phase II study in new class of oral diabetes drugs § Long-term improved glycemic control seen in patients with type II diabetes§ LAF237 shows promise as mono- and combination...
Xenova Group PLC -- Tariquidar Phase I Paediatric Study Data Presented at ASCO
June 07, 2004 02:15 ET
|
Xenova Group PLC
SLOUGH, U.K., June, 7 2004 (PRIMEZONE) -- Xenova Group plc (LSE:XEN) (Nasdaq:XNVA) announced today that the Paediatric Oncology Branch of the National Cancer Institute (NCI) in Bethesda, U.S.,...
Galapagos Reports Success in Identification and Validation of Proprietary Drug Targets and Moves into Drug Discovery
June 07, 2004 02:07 ET
|
Galapagos Genomics
MECHELEN, Belgium, June 7, 2004 (PRIMEZONE) -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has identified, validated and filed patent applications on...
Industrivarden -- Disclosure Notice
June 07, 2004 02:03 ET
|
Industrivarden
STOCKHOLM, Sweden, June 07, 2004 (PRIMEZONE) -- Industrivarden's interim report for the first quarter of 2004 reported a shareholding in Ossur hf of 52,000,000 shares as per April 30,...
Galapagos reports success in identification and validation of proprietary drug targets and moves into drug discovery.
June 07, 2004 02:00 ET
|
Galapagos NV
Mechelen, Belgium, June 7th, 2004 -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has identified, validated and filed patent applications on several novel...
Actelion Provides Update on its Clinical Programs
June 07, 2004 01:25 ET
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, June 7, 2004 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN):
-- Pivotal tezosentan (VeletriTM) study in Acute Heart Failure
passes first futility analysis
-- Second...
PrimeZone Expands Media Reach in Asia
June 06, 2004 21:00 ET
|
GlobeNewswire, Inc.
LOS ANGELES, June 6, 2004 (PRIMEZONE) -- PrimeZone Media Network today announced a major expansion of its Asian media distribution.
The newly developed PrimeZone Asia Distribution Network reaches...
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
- July 26, 2024 16:30 ET Arhaus Unveils Showroom in Palo Alto, California